Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
Clinical Pharmacology and Therapeutics|December 23, 2025
Lower Dose-Normalized Tacrolimus Exposure in CYP3A5*6 vs. *3 Loss-of-Function Allele Carriers: A Longitudinal Retrospective Real-World Study in Kidney Transplant RecipientsAmar D Levens, Dirk Jan A R Moes, Yanick Boer, et al.
Clinical Pharmacology and Therapeutics|January 28, 2023
Genome-wide Association Study of Methotrexate-Induced Liver Injury in Rheumatoid Arthritis PatientsFrank Eektimmerman, Jesse J Swen, Alfons A den Broeder, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 15, 2025
Toward an integrated resource for pharmacogenomics (PGx): Survey findings from the genomic medicine communitiesClarissa J Klein, Li Gong, Kelly E Caudle, et al.
Clinical Pharmacology and Therapeutics|February 10, 2023
Development and Bioequivalence of 3D-Printed Medication at the Point-of-Care: Bridging the Gap Toward Personalized MedicineMaryam Lyousoufi, Iris Lafeber, Dinemarie Kweekel, et al.
Pharmacogenomics|September 13, 2018
Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patientsHedy Maagdenberg, Marc B Bierings, C Heleen van Ommen, et al.
European Journal of Human Genetics : EJHG|May 28, 2026
From evidence to implementation: key priorities for pharmacogenomics-guided treatment and prevention from a European expert workshopLoes Lindiwe Kreeftenberg, Lidewij Henneman, Tessel Rigter, et al.
JCO Precision Oncology|June 8, 2026
Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A <i>DPYD</i> Variant AlleleNiels Heersche, Jonathan E Knikman, Maarten J Deenen, et al.
Clinical Pharmacology and Therapeutics|February 21, 2018
Pharmacogenetic Information in Clinical Guidelines: The European PerspectiveJesse J Swen, Marga Nijenhuis, Mandy van Rhenen, et al.
Clinical Pharmacology and Therapeutics|May 7, 2025
Implementing Pre-Emptive Pharmacogenetics: Impact of Early Pharmacogenetic Screening in a Pediatric Oncology Cohort of 1,151 SubjectsEmma C Bernsen, Eugène T P Verwiel, Maaike van der Lee, et al.
Clinical Chemistry and Laboratory Medicine|February 8, 2021
The end of the laboratory developed test as we know it? Recommendations from a national multidisciplinary taskforce of laboratory specialists on the interpretation of the IVDR and its complicationsPaul C D Bank, Leo H J Jacobs, Sjoerd A A van den Berg, et al.
Pageof 15